Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Incomplete lupus erythematosus.

J M Greer1, R S Panush

  • 1Department of Medicine, College of Medicine, University of Florida, Gainesville.

Archives of Internal Medicine
|November 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HLA and amyotrophic lateral sclerosis: a systematic review and meta-analysis.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2022
Same author

Childhood abuse and spiritual development among women religious.

Journal of religion and health·2013
Same author

Childhood abuse and spiritual development among women religious.

Journal of religion and health·2013
Same author

Optimism and coping as determinants of psychosocial adjustment to rheumatoid arthritis.

Journal of clinical psychology in medical settings·2013
Same author

Levels of phosphorylated axonal neurofilament subunit H (pNfH) are increased in acute ischemic stroke.

Journal of the neurological sciences·2011
Same author

Sexual dimorphism in autoimmune disease.

Current molecular medicine·2009
Same journal

Elevated CK-MB With Normal Total Creatine Kinase Levels in Patients Undergoing Maintenance Hemodialysis-Reply.

Archives of internal medicine·2017
Same journal

Occult Carbon Monoxide Poisoning-Reply.

Archives of internal medicine·2017
Same journal

Acquired Immune Deficiency Syndrome-Reply.

Archives of internal medicine·2017
Same journal

Heparin Side Effects-Reply.

Archives of internal medicine·2017
Same journal

Humanizing primary care medicine begins with stress.

Archives of internal medicine·2017
Same journal

Legend omitted and number misrepresented.

Archives of internal medicine·2013
See all related articles

Incomplete lupus erythematosus (ILE) patients often present with mild symptoms and fewer systemic issues compared to systemic lupus erythematosus (SLE). Most ILE cases remain stable, rarely progressing to full SLE.

Area of Science:

  • Rheumatology
  • Immunology
  • Internal Medicine

Background:

  • Incomplete lupus erythematosus (ILE) is characterized by fewer than four American College of Rheumatology criteria for systemic lupus erythematosus (SLE).
  • Understanding ILE's clinical course and comparison with SLE is crucial for diagnosis and management.

Purpose of the Study:

  • To compare the clinical features, disease course, and treatment of patients with ILE versus those with SLE.
  • To determine the potential for ILE to evolve into SLE.

Main Methods:

  • Retrospective comparison of 38 ILE patients with 42 SLE patients.
  • Analysis of demographic data, symptom duration, clinical manifestations, treatment, and disease progression.

Main Results:

Related Experiment Videos

  • ILE patients had longer symptom duration before care (38 vs. 9 months) but shorter follow-up (19 vs. 30 months).
  • Common ILE features included positive antinuclear antibody titers (83%), arthritis (47%), and skin findings (61%), similar to SLE.
  • ILE patients exhibited significantly fewer systemic manifestations and received less aggressive treatments (NSAIDs more frequent; corticosteroids/immunosuppressives less frequent).
  • Only two ILE patients progressed to typical SLE.

Conclusions:

  • ILE is a potentially frequent, milder condition with fewer systemic features than SLE.
  • ILE appears relatively stable or benign, with slow or no evolution into SLE or other rheumatic diseases.
  • ILE management may involve less aggressive therapies compared to SLE.